Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Open-Label Dose-Escalation Study of the Safety of Adoptively Transferred Autologous CD8+ T Lymphocytes Targeting HPV-16 E6/E7, HPV-18 E6/E7 and Survivin in Patients With Relapsed or Refractory HPV-related Oropharyngeal Cancers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05582590
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:21.693193+00:00
Published At
2024-01-16T00:00:00+00:00
Record Updated At
2024-01-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Oropharyngeal Cancer", "Human Papilloma Virus", "Head and Neck Cancer", "Head and Neck Squamous Cell Carcinoma", "Oropharyngeal Squamous Cell Carcinoma", "Oropharyngeal Cancer, Metastatic", "Head and Neck Cancer Metastatic", "HPV-Related Squamous Cell Carcinoma", "HPV-Related Mucosal Head and Neck Squamous Cell Carcinoma", "Relapsed Oropharyngeal SCC", "Refractory Oropharyngeal Squamous Cell Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-01-16"
protocolSection.identificationModule.nctId
"NCT05582590"
protocolSection.identificationModule.officialTitle
"A Phase 1 Open-Label Dose-Escalation Study of the Safety of Adoptively Transferred Autologous CD8+ T Lymphocytes Targeting HPV-16 E6/E7, HPV-18 E6/E7 and Survivin in Patients With Relapsed or Refractory HPV-related Oropharyngeal Cancers"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Oropharyngeal Cancer (protocolSection.conditionsModule.conditions)
  • Human Papilloma Virus (protocolSection.conditionsModule.conditions)
  • Head and Neck Cancer (protocolSection.conditionsModule.conditions)
  • Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Oropharyngeal Cancer, Metastatic (protocolSection.conditionsModule.conditions)
  • Head and Neck Cancer Metastatic (protocolSection.conditionsModule.conditions)
  • HPV-Related Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV-Related Mucosal Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Relapsed Oropharyngeal SCC (protocolSection.conditionsModule.conditions)
  • Refractory Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.